2019 Global Coronavirus Infection Market Research Report with Industry Forecast 2025 and Outlook | Analytical Research Cognizance

2019 Global Coronavirus Infection Market Research Report with Industry Forecast 2025 and Outlook

Published by
Report ID 944580
Published date Apr 27, 2020
Category Pharmaceuticals and Healthcare
Total Pages 106
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

The Coronaviruses are a group of allied viruses that affects mammals and birds. This virus can cause respiratory tract infections in humans ranging from mild to severe. Mild diseases include some common cold, while more severe varieties can cause MERS, SARS and COVID-19. This virus mainly belongs to either of the two subfamilies, Torovirinae or Coronavirinae which affects mammals' respiratory tract generally. The virus is named after its crown-like appearance and it means crown in Latin. Human coronavirus was first discovered from naval cavities in common cold patients in the early 1960s. These viruses cause lethal human infections from common cold to severe respiratory problems. Coronavirus can spread through droplets, i.e. through sneezing or coughing and there is a possibility that this huge family of viruses can also spread through close contacts with the ability to pass from person to person. Fever, Sore throat, respiratory infection, coughing and difficulty in breathing are some of the most common symptoms of coronavirus symptoms.

Increasing in the disposable income in emerging countries, growth in the rate of communicable diseases, increasing people's health hygiene and increasing number of hospitals across the globe are the main drivers of the growth in the coronavirus infection market. Innovation in treating the respiratory infections and technological advancements also triggered the growth of the coronavirus infection market.

The global coronavirus infection market is segmented on the basis of the infections, application and geography. On the basis of the infections caused by coronavirus, the market is be segmented into New Haven CoV (causes Kawasaki disease), HCoV-229E (pneumonia, causes common cold and bronchiolitis), SARS-CoV (this causes severe acute respiratory syndrome (SARS)), HCoV-OC43 (it causes respiratory tract pneumonia and infection in infants), HKU1-CoV (bilateral pneumonia and acute respiratory distress is caused), MERS-CoV (causes bronchial infections).

On the basis of application, the global coronavirus infection market is segmented into hospital, clinics and others. Geographically, the market is divided into North America, Europe, Asia-Pacific (APAC), Latin America and Middle East & Africa (MEA). The coronavirus infection market has been further segmented into respective countries. The report overall covers 20 countries and regions combined, globally.

The key players operating within the global coronavirus infection market includes Novavax, Inc., GGeneCure, LLC, Protein Potential, LLC, AlphaVax, Inc., Inovio Pharmaceuticals, Inc., NanoViricides, Inc., Synairgen plc, among others.

Chapter One: Market Introduction

Chapter Two: Executive Summary

Chapter Three: Global Personal Protective Equipment For COVID-19 Market – Key Infection Dynamics
3.1 Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints

Chapter Four: Global Personal Protective Equipment For COVID-19 Market – Analysis and Revenue Forecast, 2015-2025 – By Infection
4.1 New Haven CoV
4.2. HCoV-229E
4.3. SARS-CoV
4.4. HCoV-OC43
4.5. HKU1-CoV
4.6. MERS-CoV

Chapter Five: Global Personal Protective Equipment For COVID-19 Market – Analysis and Revenue Forecast, 2015-2025 – By Application
5.1 Hospitals
5.2. Clinics
5.3. Others

Chapter Six: Global Personal Protective Equipment For COVID-19 Market – Analysis and Revenue Forecast, 2015-2025 – By Region
6.1 North America
6.2. Europe
6.3. Asia-Pacific
6.4. Latin America
6.5. Middle East & Africa

Chapter Seven: North America Personal Protective Equipment For COVID-19 Market – Analysis and Revenue Forecast, 2015-2025
7.1 North America Personal Protective Equipment For COVID-19 Market – By Infection, 2015-2025
7.1 1. New Haven CoV
7.1 2. HCoV-229E
7.1 3. SARS-CoV
7.1 4. HCoV-OC43
7.1 5. HKU1-CoV
7.1 6. MERS-CoV
7.2. North America Personal Protective Equipment For COVID-19 Market – By Application, 2015-2025
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Others
7.3. North America Personal Protective Equipment For COVID-19 Market – By Country, 2015-2025
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico

Chapter Eight: Europe Personal Protective Equipment For COVID-19 market – Analysis and Revenue Forecast, 2015-2025
8.1 Europe Personal Protective Equipment For COVID-19 Market – By Hazard, 2015-2025
8.1 1. New Haven CoV
8.1 2. HCoV-229E
8.1 3. SARS-CoV
8.1 4. HCoV-OC43
8.1 5. HKU1-CoV
8.2. Europe Personal Protective Equipment For COVID-19 Market – By Application, 2015-2025
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Others
8.3. Europe Personal Protective Equipment For COVID-19 Market – By Country, 2015-2025
8.3.1. Germany
8.3.2. France
8.3.3. UK
8.3.4. Spain
8.3.5. Italy
8.3.6. Rest of Europe

Chapter Nine: Asia-Pacific Personal Protective Equipment For COVID-19 market – Analysis and Revenue Forecast, 2015-2025
9.1 Asia-Pacific Personal Protective Equipment For COVID-19 Market – By Hazard, 2015-2025
9.11. New Haven CoV
9.12. HCoV-229E
9.13. SARS-CoV
9.14. HCoV-OC43
9.15. HKU1-CoV
9.16. MERS-CoV
9.2. Asia-Pacific Personal Protective Equipment For COVID-19 Market – By Application, 2015-2025
9.2.1. Hospitals
9.2.2. Clinics
9.2.3. Others
9.3. Asia-Pacific Personal Protective Equipment For COVID-19 Market – By Country, 2015-2025
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Rest of Asia-Pacific

Chapter Ten: Latin America Personal Protective Equipment For COVID-19 Market – Analysis and Revenue Forecast, 2015-2025
10.1 Latin America Personal Protective Equipment For COVID-19 Market – By Hazard, 2015-2025
10.11. New Haven CoV
10.12. HCoV-229E
10.13. SARS-CoV
10.14. HCoV-OC43
10.15. HKU1-CoV
10.16. MERS-CoV
10.2. Latin America Personal Protective Equipment For COVID-19 Market – By Application, 2015-2025
10.2.1. Hospitals
10.2.2. Clinics
10.2.3. Others
10.3. Latin America Personal Protective Equipment For COVID-19 Market – By Country, 2015-2025
10.3.1. Brazil
10.3.2. Rest of Latin America

Chapter Eleven: Middle East & Africa Personal Protective Equipment For COVID-19 Market – Analysis and Revenue Forecast, 2015-2025
11.1Middle East & Africa Personal Protective Equipment For COVID-19 Market – By Hazard, 2015-2025
11.1.1. New Haven CoV
11.1.2. HCoV-229E
11.1.3. SARS-CoV
11.1.4. HCoV-OC43
11.1.5. HKU1-CoV
11.1.6. MERS-CoV
11.2. Middle East & Africa Personal Protective Equipment For COVID-19 Market – By Application, 2015-2025
11.2.1. Hospitals
11.2.2. Clinics
11.2.3. Others
11.3. Middle East & Africa Personal Protective Equipment For COVID-19 Market – By Country, 2015-2025
11.3.1. UAE
11.3.2. Saudi Arabia
11.3.3. Turkey
11.3.4. Rest of Middle East & Africa

Chapter Twelve: Competitive Analysis
12.11. Competition Dashboard
12.12. Company Profiles
12.12.1. Novavax, Inc
12.12.1.1. Company Details
12.12.1.2. Application Portfolio
12.12.1.3. Financial Overview
12.12.1.4. Main Business Overview
12.12.1.5. News
12.12.2. GGeneCure, LLC
12.12.3. Protein Potential, LLC
12.12.4. AlphaVax, Inc.
12.12.5. Inovio Pharmaceuticals, Inc.
12.12.6. NanoViricides, Inc.
12.12.7. Synairgen plc

N/A